MADDALONI, ERNESTO
 Distribuzione geografica
Continente #
NA - Nord America 2.784
EU - Europa 848
AS - Asia 561
AF - Africa 26
SA - Sud America 16
OC - Oceania 14
Totale 4.249
Nazione #
US - Stati Uniti d'America 2.729
IT - Italia 426
SG - Singapore 280
SE - Svezia 203
IN - India 132
CN - Cina 102
CA - Canada 49
DE - Germania 29
IE - Irlanda 26
ID - Indonesia 25
UA - Ucraina 25
FI - Finlandia 22
RO - Romania 21
TG - Togo 21
FR - Francia 20
BG - Bulgaria 18
GB - Regno Unito 17
AU - Australia 13
NL - Olanda 10
AR - Argentina 8
ES - Italia 7
MX - Messico 6
BE - Belgio 5
BR - Brasile 5
MY - Malesia 5
PL - Polonia 5
RU - Federazione Russa 4
SY - Repubblica araba siriana 4
CL - Cile 3
HK - Hong Kong 3
KR - Corea 3
TH - Thailandia 3
AL - Albania 2
AT - Austria 2
DK - Danimarca 2
IQ - Iraq 2
NG - Nigeria 2
PH - Filippine 2
ZA - Sudafrica 2
GR - Grecia 1
HU - Ungheria 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TZ - Tanzania 1
Totale 4.249
Città #
Fairfield 527
Woodbridge 225
Seattle 209
Ashburn 197
Rome 196
Singapore 192
Houston 189
Cambridge 175
Chandler 162
Wilmington 160
Ann Arbor 86
Princeton 77
Millbury 68
Beijing 65
San Paolo di Civitate 58
Lawrence 57
San Diego 55
Santa Clara 47
Plano 46
Ottawa 31
Andover 26
Dublin 26
New York 26
Jakarta 25
Lomé 21
Sofia 18
Boston 17
Toronto 15
Norwalk 14
Stockholm 13
Boardman 12
Sydney 12
Helsinki 10
Milan 10
Des Moines 9
San Mateo 9
Dearborn 7
Madrid 7
Bühl 6
Hefei 6
Induno Olona 6
Mannheim 6
Munich 6
Brussels 5
Federal 5
Fremont 5
London 5
Los Angeles 5
Dallas 4
Falkenstein 4
Messina 4
Venafro 4
Bangkok 3
Barrie 3
Belo Horizonte 3
Chicago 3
Chieti 3
Gwanak-gu 3
Hebei 3
Hong Kong 3
Lingolsheim 3
Mexico City 3
Molfetta 3
Nanjing 3
Naples 3
Southend 3
Târgu Mureş 3
Albuquerque 2
Arezzo 2
Bedong 2
Catanzaro 2
Copenhagen 2
Fontanellato 2
Fort Myers 2
Fort Worth 2
Guangzhou 2
Hyderabad 2
Innsbruck 2
Ipoh 2
Johannesburg 2
Kirkuk 2
Kunming 2
Latina 2
Livorno 2
Menlo Park 2
Moscow 2
Nagpur 2
Nanchang 2
Pagani 2
Pomigliano d'Arco 2
Santarcangelo di Romagna 2
Shanghai 2
Termini Imerese 2
Tirana 2
Vicente López 2
Villaricca 2
Warsaw 2
Acton 1
Agawam 1
Amsterdam 1
Totale 3.278
Nome #
Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial 109
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 104
Adult-onset autoimmune diabetes: current knowledge and implications for management 95
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) 93
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis 88
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes 87
Wrist circumference is a biomarker of adipose tissue dysfunction and cardiovascular risk in children with obesity 84
Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement 82
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 78
Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity 76
Frailty and geography: Should these two factors be added to the ABCDE contemporary guide to diabetes therapy? 76
In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes 74
Osteocalcin and sclerostin. Background characters or main actors in cardiovascular disease? 74
Combination immunotherapies for type 1 diabetes mellitus 70
New strategy to study the impact of ethnicity on diabetic neuropathy 70
Diabetes-related autoantibodies in children with acute lymphoblastic leukemia 69
Chitotriosidase Activity Is Inversely Associated with Diastolic Blood Pressure and HbA1c but Not with Arterial Stiffness in Patients with Type 2 Diabetes without Complications 69
Comment on: "Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results" 68
Comparison of lipid-lowering medications and risk for cardiovascular disease in diabetes 68
Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy 67
Continuous glucose monitoring and robot surgery of an insulinoma: a case report and review of the literature 67
Why China guidelines for type 2 diabetes represent an opportunity for treating this disease 66
Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence? 66
Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes. 65
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies 65
Bone Microarchitecture in Type 1 Diabetes: It Is Complicated 65
Long-term Risk of Cardiovascular Disease in Individuals with Latent Autoimmune Diabetes of Adults (UKPDS 85) 64
Bone health in subjects with type 1 diabetes for more than 50 years 63
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism 63
Cardiovascular effects of SGLT-2 inhibitors: what we have learned from cardiovascular outcome trials and what we still need to understand 62
Why only macro and not micro in type 2 diabetes? Time to change the goals of clinical trials in diabetes 62
High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja 62
Adult-onset autoimmune diabetes in 2020: an update 62
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes 61
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study 60
Vitamin D and Diabetes Mellitus 59
Prevention of atherothrombotic events in patients with diabetes mellitus. From antithrombotic therapies to new-generation glucose-lowering drugs 59
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: a 24 months follow-up study 59
Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: A case report 58
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 58
SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes) 58
Risk factors for fragility fractures in type 1 diabetes 58
PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life 58
Diabetes: the disease of the 10 D 57
Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules 57
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes 56
Correction to: "H" for heterogeneity in the algorithm for type 2 diabetes management 55
Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial 54
Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function 54
Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis 53
Insulin decreases atherosclerosis by inducing endothelin receptor B expression 52
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes. A cross-sectional study 50
In vivo corneal confocal microscopy in diabetes: Where we are and where we can get 48
Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease 48
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes 48
Serum 25-OH Vitamin D in relation to Bone Mineral Density and Bone Turnover 46
New technologies aiding dietary programmes for weight control: the oral glucose spray 45
Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease 44
Effects of covid-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy 42
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86) 41
Effectiveness and safety of calcium and vitamin D treatment for postmenopausal osteoporosis 40
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome 40
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective 40
Development of a clinical risk score to predict death in patients with COVID-19 39
null 38
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 38
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study 36
Risk factors and predictive biomarkers of early cardiovascular disease in obese youth 36
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths 36
Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril-valsartan: does money matter? 35
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics 33
Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes 30
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study. The CoVaDiab study I 29
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 29
Adult-onset autoimmune diabetes 28
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes 27
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: a 12‐month, randomized, comparator‐controlled pilot study 27
SGLT-2 inhibitors on top of current pharmacological treatments for heart failure: a comparative review on outcomes and cost effectiveness 25
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 24
Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment. A Pilot Study 22
Il ruolo del biostatistico nella preparazione conduzione e monitoraggio delle sperimentazioni cliniche 22
Tipo 1 e LADA in crescita: prevenzione e assistenza ottimale 22
The vicious circle of left ventricular dysfunction and diabetes: from pathophysiology to emerging treatments 22
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications 19
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study 17
null 17
Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication 16
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA 13
Serum chitotriosidase in postmenopausal women with severe osteoporosis 12
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study 11
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials 10
Updates on Glycaemic Control Strategies: A Range of Opportunities after Total Pancreatectomy 10
Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes 6
Obesity in type 1 diabetes: an overlooked immune-metabolic issue 6
Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules 6
Relationship between Muscle Mass, Bone Density and Vascular Calcifications in Elderly People with SARS-CoV-2 Pneumonia 5
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial 5
Serum chitotriosidase in postmenopausal women with severe osteoporosis 3
Questions and answers on the use of aspirin for primary prevention of cardiovascular disease in diabetes 2
Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis 2
Totale 4.749
Categoria #
all - tutte 15.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020754 0 0 0 0 105 100 130 124 109 79 59 48
2020/2021700 48 34 33 18 7 38 13 19 73 171 128 118
2021/2022851 13 16 47 54 109 49 34 77 85 67 162 138
2022/2023899 178 170 66 94 58 92 28 68 60 25 45 15
2023/2024479 35 38 13 25 48 61 18 25 7 80 55 74
2024/2025386 33 88 107 86 72 0 0 0 0 0 0 0
Totale 4.754